Multiscale networks in Alzheimer’s disease identify brain hypometabolism as central across biological scales
PLOS Computational Biology · 2025
DOI: 10.1371/journal.pcbi.1013583 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Computational Biology, 2025. Verfasst von Elena Lara-Simon und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona, Spain. Hauptthemen laut MEDLINE: Alzheimer Disease, Brain. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, Ministerio de Ciencia e Innovación, Institució Catalana de Recerca i Estudis Avançats.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer’s disease encompasses multiple biological scales, spanning molecular factors, cells, tissues, and behavioral manifestations. The interplay among these scales in shaping the clinical phenotype is not yet fully comprehended. In particular, there is great interest in understanding the heterogeneity of the clinical aspects of AD in order to improve treatment and prevention, by targeting those aspects most susceptible to the disease. Here we employed a systems biology approach to address this issue, utilizing multilayer network analysis and deep phenotyping. This integrative analysis incorporated genomics, cerebrospinal fluid biomarkers, tau and amyloid beta (A β ) PET imaging, brain MRI data, risk factors, and clinical information (cognitive tests scores, Clinical Dementia Rating and clinical diagnosis) obtained through the ADNI collaboration. Multilayer networks were built based on mutual information between the elements of each layer and between layers. Boolean simulations allowed us to identify paths that transmit dynamic information across layers. The most prominent path for predicting variables in the cognitive phenotype layer included the PET radiotracer fluorodeoxyglucose (FDG) in the posterior cingulate. Combinations of different symptomatic variables, mainly related to mental health (depression, mood swings, drowsiness) and vascular features (hypertension, cardiovascular history), were also part of the paths explaining the average phenotype. Our results show that integrating the flow of information across biological scales reveals relevant paths for AD, which can be subsequently explored as potential biomarkers or therapeutic targets. In particular, our results point for paths related with brain hypometabolism as a key feature in AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona, Spain.
- Barcelona Beta Research Center, Barcelona, Spain.
- Hospital del Mar Research Institute, Barcelona, Spain.
ORCID-Profile: Elena Lara-Simon, Jordi Garcia-Ojalvo, Pablo Villoslada
Förderung
- NIA NIH HHS
- Ministerio de Ciencia e Innovación
- Institució Catalana de Recerca i Estudis Avançats
Zitieren
APA
Lara-Simon, E., Gispert, J. D., Garcia-Ojalvo, J., Villoslada, P., & Alzheimer’s Disease Neuroimaging Initiative (2025). Multiscale networks in Alzheimer’s disease identify brain hypometabolism as central across biological scales. PLOS Computational Biology. https://doi.org/10.1371/journal.pcbi.1013583
Vancouver
Lara-Simon E, Gispert JD, Garcia-Ojalvo J, Villoslada P, Alzheimer’s Disease Neuroimaging Initiative. Multiscale networks in Alzheimer’s disease identify brain hypometabolism as central across biological scales. PLOS Computational Biology. 2025. doi:10.1371/journal.pcbi.1013583
BibTeX
@article{LaraSimon2025,
author = {Lara-Simon, Elena and Gispert, Juan Domingo and Garcia-Ojalvo, Jordi and Villoslada, Pablo and Alzheimer’s Disease Neuroimaging Initiative, Alzheimer’s Disease Neuroimaging Initiative},
title = {Multiscale networks in Alzheimer’s disease identify brain hypometabolism as central across biological scales},
journal = {PLOS Computational Biology},
year = {2025},
doi = {10.1371/journal.pcbi.1013583}
}
EUVIMED